HUP9701717A2 - Eljárás cPSA-meghatározására - Google Patents

Eljárás cPSA-meghatározására

Info

Publication number
HUP9701717A2
HUP9701717A2 HU9701717A HUP9701717A HUP9701717A2 HU P9701717 A2 HUP9701717 A2 HU P9701717A2 HU 9701717 A HU9701717 A HU 9701717A HU P9701717 A HUP9701717 A HU P9701717A HU P9701717 A2 HUP9701717 A2 HU P9701717A2
Authority
HU
Hungary
Prior art keywords
cpsa
subject
prostate cancer
determination
prostate
Prior art date
Application number
HU9701717A
Other languages
English (en)
Inventor
William Jeffrey Allard
Kwok K. Yeung
Zeqi Zhou
Original Assignee
Bayer Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419236&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9701717(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/903,750 external-priority patent/US5840501A/en
Application filed by Bayer Corporation filed Critical Bayer Corporation
Publication of HU9701717D0 publication Critical patent/HU9701717D0/hu
Publication of HUP9701717A2 publication Critical patent/HUP9701717A2/hu
Publication of HUP9701717A3 publication Critical patent/HUP9701717A3/hu
Publication of HU221350B1 publication Critical patent/HU221350B1/hu

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány tárgya eljárás imműnőlógiailag kiműtathatóprősztataspecifikűs antigén (PSA) kőmplexben kötött főrmáinak (cPSA)vérmintából történő meghatárőzására, kétkötőhelyű imműnőmetriásvizsgálati eljárás alkalmazásával. A találmány tárgyát képezik tővábbáeljárásők prősztatarák diagnősztizálásának elősegítésére ésprősztatarákős páciensek állapőtának nyőmőnkövetésére a találmányszerinti vizsgálati eljárás alkalmazásával.A találmány szerinti megőldás előnyösen alkalmazható a klinikaidiagnősztika területén, közelebbről a prősztatarák diagnősztizálásaterületén.ŕ
HU9701717A 1996-10-25 1997-10-22 Determination of cpsa HU221350B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73838396A 1996-10-25 1996-10-25
US83496997A 1997-04-07 1997-04-07
US08/903,750 US5840501A (en) 1996-10-25 1997-07-31 Determination of cPSA

Publications (4)

Publication Number Publication Date
HU9701717D0 HU9701717D0 (en) 1997-12-29
HUP9701717A2 true HUP9701717A2 (hu) 1998-05-28
HUP9701717A3 HUP9701717A3 (en) 2000-04-28
HU221350B1 HU221350B1 (en) 2002-09-28

Family

ID=27419236

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701717A HU221350B1 (en) 1996-10-25 1997-10-22 Determination of cpsa

Country Status (14)

Country Link
US (2) US5928878A (hu)
EP (1) EP0838680B1 (hu)
JP (1) JP4274330B2 (hu)
AT (1) ATE267399T1 (hu)
AU (1) AU746345B2 (hu)
CA (1) CA2214488C (hu)
CZ (1) CZ295854B6 (hu)
DE (1) DE69729156T2 (hu)
DK (1) DK0838680T3 (hu)
ES (1) ES2221006T3 (hu)
HU (1) HU221350B1 (hu)
IL (1) IL121659A (hu)
NO (1) NO974534L (hu)
PT (1) PT838680E (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19641560A1 (de) * 1996-10-09 1998-04-16 Boehringer Mannheim Gmbh Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease
CA2243033A1 (en) * 1997-07-31 1999-01-31 Bayer Corporation Determination of psa-act
AU1682699A (en) * 1997-12-25 1999-07-19 Japan Tobacco Inc. Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
CA2311512A1 (en) * 1999-07-24 2001-01-24 Bayer Corporation Reflex method for the detection of prostate cancer
JP3536731B2 (ja) * 1999-07-28 2004-06-14 富士レビオ株式会社 ＨＩＶ−１ｐ２４抗原の免疫測定方法及び試薬
US6569684B2 (en) 2000-01-06 2003-05-27 University Of Central Florida Method of identifying and treating invasive carcinomas
US6379550B1 (en) 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel
ATE282205T1 (de) 2000-07-24 2004-11-15 Health Research Inc Verfahren zur detektion von prostata-spezifischem membran-antigen in serum
EP1307585B1 (en) 2000-08-07 2009-01-21 Vanderbilt University Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
JP2004510161A (ja) * 2000-09-25 2004-04-02 アボット・ラボラトリーズ 高分子ポリカチオンを用いることにより、特異的結合アッセイにおける血清または血漿含有アッセイ試料の干渉を減少させるための方法及びキット
US6764825B1 (en) * 2000-10-13 2004-07-20 Tang J. Wang Methods and device for detecting prostate specific antigen (PSA)
US6838264B2 (en) * 2000-12-05 2005-01-04 Immutopics, Inc. Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
US7226749B2 (en) * 2000-12-05 2007-06-05 Zahradnik Richard J Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
JP4256265B2 (ja) * 2002-03-13 2009-04-22 ベーイーオー・メリュー 循環腫瘍細胞の検出および／または定量方法、およびその方法の早期診断、予後診断、および再発診断への使用、ならびにその方法の治療的処置の選択および評価への使用
US20040018580A1 (en) * 2002-05-10 2004-01-29 Chai Karl X. Synthetic substrates for prostasin
US7666981B1 (en) 2002-05-10 2010-02-23 University Of Central Florida Research Foundation, Inc. Inhibitors of prostasin
US7314709B2 (en) * 2002-08-06 2008-01-01 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism
EP1507147A1 (en) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Method for detecting low levels of a fusion protein
EP1709448B1 (en) * 2004-01-28 2008-10-22 Turun Yliopisto Improved method for diagnosing acute coronary syndrome
US8012694B2 (en) 2006-09-14 2011-09-06 Immutopics, Inc. Assay for the detection of phosphorylated PTH
EP2107377A1 (en) * 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events
JP5415520B2 (ja) * 2008-04-09 2014-02-12 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 最大酸素消費量低下の予測のためのプロ−エンドセリン−１
US8658164B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8632971B2 (en) 2011-11-08 2014-01-21 Caldera Health Limited Methods and materials for determining the efficacy of prostate cancer therapies
US20130116131A1 (en) 2011-11-08 2013-05-09 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8658166B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
JP6604081B2 (ja) * 2014-08-13 2019-11-13 東ソー株式会社 Ｎ型糖鎖が付加している膵臓リボヌクレアーゼ１の測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0690203B2 (ja) * 1985-08-23 1994-11-14 中外製薬株式会社 前立腺特異抗原とα▲下１▼−アンチトリプシン複合体の定量方法
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
DE4322342A1 (de) * 1993-07-05 1995-02-09 Gif Ges Fuer Immunologische Fo Verfahren für die Differentialdiagnostik des Prostata-Karzinoms
EP0635575A1 (en) * 1993-07-22 1995-01-25 Wallac Oy Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5698402A (en) * 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US5710007A (en) * 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma

Also Published As

Publication number Publication date
DE69729156D1 (de) 2004-06-24
AU3926797A (en) 1998-04-30
CA2214488A1 (en) 1998-04-25
PT838680E (pt) 2004-08-31
HU9701717D0 (en) 1997-12-29
DK0838680T3 (da) 2004-09-27
ATE267399T1 (de) 2004-06-15
CZ295854B6 (cs) 2005-11-16
EP0838680B1 (en) 2004-05-19
IL121659A (en) 2000-07-16
IL121659A0 (en) 1998-02-22
EP0838680A1 (en) 1998-04-29
US6107049A (en) 2000-08-22
NO974534L (no) 1998-04-27
ES2221006T3 (es) 2004-12-16
NO974534D0 (no) 1997-10-01
HU221350B1 (en) 2002-09-28
CA2214488C (en) 2007-06-19
HUP9701717A3 (en) 2000-04-28
JPH10177027A (ja) 1998-06-30
US5928878A (en) 1999-07-27
DE69729156T2 (de) 2005-05-25
JP4274330B2 (ja) 2009-06-03
AU746345B2 (en) 2002-04-18
CZ335797A3 (cs) 1998-05-13

Similar Documents

Publication Publication Date Title
HUP9701717A2 (hu) Eljárás cPSA-meghatározására
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
DK0516746T3 (da) Oral opsamling til immunoassay
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
DE69618447D1 (de) Frühzeitiger nachweis von prostatakrebs (cap) durch bestimmung des konzentrationsverhältnisses zwischen prostataspezifischem antigen (psa) und menschlichem drüsenkallikrein (hgk-1)
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DK0807124T3 (da) Monoklonalt antistof mod FLT4-receptor-tyrosinkinase og anvendelse heraf i diagnose og terapi
DE3780480D1 (de) Test fuer menschlichen brustkrebs.
DE69713146D1 (de) Helicobacter pylori diagnostika
ATE404676T1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
EP1276771A4 (en) SENSITIVE DETECTION OF EGFR MUTANTS AND GAME TYPE BY SPECIFIC ELISA DETECTION IN ANY BIOLOGICAL SAMPLE
ATE429440T1 (de) Formen prostataspezifischer antigene und verfahren zu deren nachweis
ATE305140T1 (de) Verfahren zur detektion der hk2 polypeptide
DK1200826T3 (da) Immunoassay og testanordning med integreret reference
DE69811157D1 (de) Immunoassay zur Bestimmung von PSA-ACT
DE3485740D1 (de) Immunologisches testverfahren eines prokoagulierenden enzyms zum nachweis von krebs.
RU2001118921A (ru) Способ мониторинга за состоянием пациентов с воспалительно-деструктивными процессами для оценки степени выраженности тканевой деструкции с помощью иммуноферментной тест-системы эли-г-иф

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees